Literature DB >> 15918585

A simple predictive model for blood-brain barrier penetration.

X C Fu1, Z F Song, C Y Fu, W Q Liang.   

Abstract

A simple two-descriptor model to predict blood-brain barrier penetration is derived from a training set of 79 compounds: log BB = - 13.31V2 + 9.601V - 2.231PSA - 0.5290 (n = 79, r2 = 0.83) where log BB is the logarithm of the ratio of the steady-state concentration of the compound in the brain to in the blood, V (nm3) is the molecular volume, PSA (nm2) is the polar surface area which is defined as the sum of the van der Waals surface areas of oxygen atoms, nitrogen atoms, and attached hydrogen atoms in a molecule, n is the number of compounds, and r is the correlation coefficient. The model is validated by a leave-one-out procedure and an external test set (25 compounds). The results indicate that the model developed is statistically sound and is sufficiently reliable and robust for predictive use. The descriptors in the model can be easily computed and it is suitable for the rapid prediction of the blood-brain barrier penetration for a wide range of drug candidates.

Entities:  

Mesh:

Year:  2005        PMID: 15918585

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  5 in total

Review 1.  Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery.

Authors:  Mohammad S Alavijeh; Mansoor Chishty; M Zeeshan Qaiser; Alan M Palmer
Journal:  NeuroRx       Date:  2005-10

2.  2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.

Authors:  Deniz Tasdemir; David Sanabria; Ina L Lauinger; Alice Tarun; Rob Herman; Remo Perozzo; Mire Zloh; Stefan H Kappe; Reto Brun; Néstor M Carballeira
Journal:  Bioorg Med Chem       Date:  2010-09-18       Impact factor: 3.641

3.  MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist.

Authors:  Heather N Richardson; Yu Zhao; Eva M Fekete; Cindy K Funk; Peter Wirsching; Kim D Janda; Eric P Zorrilla; George F Koob
Journal:  Pharmacol Biochem Behav       Date:  2007-10-23       Impact factor: 3.533

4.  CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats.

Authors:  Sheila E Specio; Sunmee Wee; Laura E O'Dell; Benjamin Boutrel; Eric P Zorrilla; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2007-10-30       Impact factor: 4.530

5.  Predicting the Blood-Brain Barrier Permeability of New Drug-Like Compounds via HPLC with Various Stationary Phases.

Authors:  Małgorzata Janicka; Małgorzata Sztanke; Krzysztof Sztanke
Journal:  Molecules       Date:  2020-01-23       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.